
Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …

Gliomas are among the most common primary malignant brain tumours

Cambridge-based AI company, Lucida Medical, has received CE marking for its new machine learning-based prostate cancer detection software, Prostate Intelligence …

Medical imaging company, Guerbet, have announced the success of its Phase III study into the safety and efficacy of Gadopiclenol, …

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …

Bayer and Regeneron’s Eylea has added to a growing list of indications with its new approval to treat a type …